Page last updated: 2024-10-19

phenylacetic acid and Lymphoma, Non-Hodgkin

phenylacetic acid has been researched along with Lymphoma, Non-Hodgkin in 1 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.

Research Excerpts

ExcerptRelevanceReference
" The goals of this study were to determine whether PA and PB (a) are cytotoxic to malignant B cells from patients with non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia and (b) exhibit additive or synergistic induction of apoptosis when administered to myeloma cell lines in combination with conventional drugs."1.31Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents. ( Kaufmann, SH; Stenson, M; Svingen, PA; Timm, M; Witzig, TE, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Witzig, TE1
Timm, M1
Stenson, M1
Svingen, PA1
Kaufmann, SH1

Other Studies

1 other study available for phenylacetic acid and Lymphoma, Non-Hodgkin

ArticleYear
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; Drug Interactions; Drug Synergism; H

2000